Company Context

CareBridge is a mid-sized US telehealth platform focused on urgent care and chronic condition follow-ups. The company generated $84M revenue in 2024, serves 1.8M annual virtual visits, and currently operates in 12 states, with strongest penetration in the Southeast. It has built a profitable B2B2C model through employer plans and regional insurers, but growth has slowed as core markets mature. The CEO has asked the strategy team to assess market trends and recommend where CareBridge should focus expansion over the next 24 months.

Strategic Situation

CareBridge is considering two growth paths: (1) geographic expansion into 8 additional states, or (2) deeper expansion into behavioral health and women’s health within existing states. Management wants a structured market-trend analysis rather than a simple market size estimate. The decision matters now because several competitors have increased funding, payer reimbursement policies are shifting, and the company has budget for only one primary growth bet in the next planning cycle.

Market Data

• Current customer acquisition cost: $118 per member in existing states; estimated $210 in new states during year 1
• Average annual gross profit per active member: $164 in urgent care, $248 in behavioral health, $221 in women’s health
• Competitor MedNow raised $150M and entered 5 overlapping states in the last 9 months
• CareBridge has $18M discretionary growth budget for the next 12 months

Deliverables

As the strategy manager, prepare a recommendation for the executive team:

1. Explain how you would analyze relevant market trends, separating structural trends from short-term noise.
2. Compare the attractiveness of the two growth paths using market growth, competitive intensity, and unit economics.
3. Identify which market signals matter most for prioritization over the next 24 months.
4. Recommend one primary growth path and one secondary hedge.
5. Outline a go-to-market approach and the key metrics leadership should monitor.

Constraints

• Budget capped at $18M over 12 months
• Product and operations teams can support only one major new build-out at a time
• Board expects visible revenue impact within 12-18 months
• CareBridge cannot materially worsen EBITDA margin below 8% during expansion